Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP)
| Name | Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) |
|---|---|
| Supplier | Abcam |
| Catalog | ab20272 |
| Prices | $394.00 |
| Sizes | 100 µl |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Clone | mAbcam 8226 |
| Applications | WB |
| Species Reactivities | Mouse, Rat, Rabbit, Chicken, Bovine, Dog, Human, Pig, Drosophila, Monkey, Hamster, Sheep, Horse, Guinea Pig |
| Antigen | Synthetic peptide conjugated to KLH derived from within residues 1 - 100 of Human beta Actin |
| Description | Mouse Monoclonal |
| Gene | ACTB |
| Conjugate | HRP |
| Supplier Page | Shop |
Product images
![All lanes : Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) (ab20272) at 1/5000 dilutionLane 1 : human testis lysateLane 2 : human brain lysateLane 3 : human tonsil lysateLane 4 : mouse brain lysateLane 5 : mouse spleen lysateLysates/proteins at 20 µg per lane.developed using the ECL techniquePerformed under reducing conditions.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_1/13693_ab20272%2520datasheet%25202%2520copy.jpg)
All lanes : Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) (ab20272) at 1/5000 dilutionLane 1 : human testis lysateLane 2 : human brain lysateLane 3 : human tonsil lysateLane 4 : mouse brain lysateLane 5 : mouse spleen lysateLysates/proteins at 20 µg per lane.developed using the ECL techniquePerformed under reducing conditions.
![All lanes : Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) (ab20272) at 1/5000 dilutionLane 1 : HeLa whole cell lysateLane 2 : 3T3 whole cell lysateLane 3 : Rat brain lysateLysates/proteins at 20 µg per lane.developed using the ECL techniquePerformed under reducing conditions.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_1/13694_ab20272_1.jpg)
All lanes : Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) (ab20272) at 1/5000 dilutionLane 1 : HeLa whole cell lysateLane 2 : 3T3 whole cell lysateLane 3 : Rat brain lysateLysates/proteins at 20 µg per lane.developed using the ECL techniquePerformed under reducing conditions.
![Lanes 1 - 4 : Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) (ab20272) at 1/5000 dilution (Blocked in 5% BSA)Lanes 5 - 8 : Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) (ab20272) at 1/5000 dilution (Blocked in 5% MILK)Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell LysateLane 2 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell LysateLane 3 : NIH 3T3 (Mouse embryonic fibroblast cell line) Whole Cell Lysate (ab7179)Lane 4 : PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell LysateLane 5 : HeLa (Human epithelial carcinoma cell line) Whole Cell LysateLane 6 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell LysateLane 7 : NIH 3T3 (Mouse embryonic fibroblast cell line) Whole Cell Lysate (ab7179)Lane 8 : PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell LysateLysates/proteins at 10 µg per lane.developed using the ECL techniquePerformed under reducing conditions.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_1/13695_beta-Actin-Primary-antibodies-ab20272-2.jpg)
Lanes 1 - 4 : Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) (ab20272) at 1/5000 dilution (Blocked in 5% BSA)Lanes 5 - 8 : Anti-beta Actin antibody [mAbcam 8226] - Loading Control (HRP) (ab20272) at 1/5000 dilution (Blocked in 5% MILK)Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell LysateLane 2 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell LysateLane 3 : NIH 3T3 (Mouse embryonic fibroblast cell line) Whole Cell Lysate (ab7179)Lane 4 : PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell LysateLane 5 : HeLa (Human epithelial carcinoma cell line) Whole Cell LysateLane 6 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell LysateLane 7 : NIH 3T3 (Mouse embryonic fibroblast cell line) Whole Cell Lysate (ab7179)Lane 8 : PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell LysateLysates/proteins at 10 µg per lane.developed using the ECL techniquePerformed under reducing conditions.
Product References
Effect of follicular fluid and platelet-activating factor on lactate - Effect of follicular fluid and platelet-activating factor on lactate
Esmaeilpour T, Zarei MR, Bahmanpour S, Aliabadi E, Hosseini A, Jaberipour M. Iran J Med Sci. 2014 Jan;39(1):20-8.
Analysis on the relevance of asthma susceptibility with the alteration of - Analysis on the relevance of asthma susceptibility with the alteration of
Xiang Y, Zhou XY, Tan YR, Tan ML, Liu HJ, Liu C, Qu XP, Qin XQ. PLoS One. 2014 Apr 16;9(4):e95533.
Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer - Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer
Al-Souhibani N, Al-Ghamdi M, Al-Ahmadi W, Khabar KS. Carcinogenesis. 2014 Sep;35(9):1983-92.
Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma. - Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.
Krook MA, Nicholls LA, Scannell CA, Chugh R, Thomas DG, Lawlor ER. Mol Cancer Res. 2014 Jun;12(6):953-64.
Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene - Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene
Kayman-Kurekci G, Talim B, Korkusuz P, Sayar N, Sarioglu T, Oncel I, Sharafi P, Gundesli H, Balci-Hayta B, Purali N, Serdaroglu-Oflazer P, Topaloglu H, Dincer P. Neuromuscul Disord. 2014 Jul;24(7):624-33.
Evidence for functional diversity between the voltage-gated proton channel Hv1 - Evidence for functional diversity between the voltage-gated proton channel Hv1
Kim IH, Hevezi P, Varga C, Pathak MM, Hong L, Ta D, Tran CT, Zlotnik A, Soltesz I, Tombola F. PLoS One. 2014 Aug 28;9(8):e105926.
Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in - Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in
Fan C, Miao Y, Zhang X, Liu D, Jiang G, Lin X, Han Q, Luan L, Xu Z, Wang E. BMC Cancer. 2014 Sep 24;14:704.
Inhibition of apelin expression switches endothelial cells from proliferative to - Inhibition of apelin expression switches endothelial cells from proliferative to
Kasai A, Ishimaru Y, Higashino K, Kobayashi K, Yamamuro A, Yoshioka Y, Maeda S. Angiogenesis. 2013 Jul;16(3):723-34.
APOBEC3G polymorphism as a selective barrier to cross-species transmission and - APOBEC3G polymorphism as a selective barrier to cross-species transmission and
Krupp A, McCarthy KR, Ooms M, Letko M, Morgan JS, Simon V, Johnson WE. PLoS Pathog. 2013;9(10):e1003641.
Presence of brown adipocytes in retroperitoneal fat from patients with benign - Presence of brown adipocytes in retroperitoneal fat from patients with benign
Betz MJ, Slawik M, Lidell ME, Osswald A, Heglind M, Nilsson D, Lichtenauer UD, Mauracher B, Mussack T, Beuschlein F, Enerback S. J Clin Endocrinol Metab. 2013 Oct;98(10):4097-104.